Response to Sriwijitalai and Wiwanitkit re: “The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case-Control Study”
Restricted accessLetterFirst published online September, 2022
Response to Sriwijitalai and Wiwanitkit re: “The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case-Control Study”
SriwijitalaiW, WiwanitkitV. Re: “The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case-Control Study” by Rayati Damavandi et al. Viral Immunol, 2022; 35(7):514; doi:10.1089/vim.2022.0077.
2.
Rayati DamavandiA, Zolfaghari BaghbadoraniP, KardidehB, et al.The association of programmed death 1 gene polymorphisms of PD1.3 G/A and PD1.5 C/T with risk of COVID-19 in an Iranian population: A case-control study. Viral Immunol, 2022; 35(7):483–490; doi: 10.1089/vim.2022.0030.